Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000146

EVP, Chief Reg. & Quality Off. sold 3,242 shares at $499.99 ($1,620,968)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-10 Sale : show line 1 in the form 10b5-1 −3,242 $499.99 $1,620,968 51,239 D
Open-market sales · 3,242 sh · avg $499.99 · $1,620,968
Loading xslF345X05/wk-form4_1741810227.xml…